Zalutumumab
|
|
667901-13-5
|
2-Chloro-4,5-dimethylbenzo[d]thiazole
|
|
252681-54-2
|
N,N'-Dimethyl-2-nitro-1,1-ethendiamine
|
|
54252-45-8
|
[Ala17]-MCH
|
|
359784-84-2
|
H-NSLFEYQK^-OH
|
|
|
2-(Iodomethyl)-oxepane
|
|
130868-43-8
|
(2R)-1-Benzoylpyrrolidine-2-carboxylic acid
|
|
115795-02-3
|
2,2,2-Trifluoroethyl pyridine-3-carboxylate hydrochloride
|
|
1803587-60-1
|
(-)-Zeylenol
|
|
78804-17-8
|
9-Ethyl-9H-carbazole-3,6-dicarbaldehyde
|
|
70207-46-4
|
3'-Ethoxyacetanilide
|
|
591-33-3
|
1-(1H-Indazol-5-yl)ethan-1-amine
|
|
1001906-62-2
|
5-Methyl-1-(oxolan-3-yl)-1H-1,2,3-triazole-4-carboxylic acid
|
|
1342071-49-1
|
3,4-Diethoxybenzene-1-sulfonamide
|
|
104296-87-9
|
1-Isocyanato-3-(propan-2-yl)benzene
|
|
55304-09-1
|
1,3-Dimethyl 2-(chloromethylidene)propanedioate
|
|
38238-77-6
|
Bisabolol oxide B
|
|
26184-88-3
|
MRAS antibody
|
|
|
[1-Methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]methanol
|
|
949898-58-2
|
1-Aminopropane-2-sulfonamide hydrochloride
|
|
1420660-61-2
|
Ferritin ELISA kit
|
|
|
2,2-Difluoro-2-[4-(trifluoromethyl)phenyl]acetic acid
|
|
73790-11-1
|
1-[2-(Pyrrolidin-1-yl)ethyl]-1H-pyrazole-4-carboxylic acid
|
|
1155065-00-1
|
Methyl 2-acetamido-4-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-2-deoxy-6-O-(a-L-fucopyranosyl)-b-D-glucopyranoside
|
|
97242-84-7
|
4-Chloro-3-nitro-5-sulfamoylbenzoic acid
|
|
22892-96-2
|
3-Chloro-6-fluoropyridin-2-amine
|
|
1232431-23-0
|
4-(4-Difluoromethoxy-phenyl)-thiazol-2-ylamine
|
|
105512-78-5
|
4-[(tert-Butoxy)carbonyl]-2-(prop-2-en-1-yl)morpholine-2-carboxylic acid
|
|
1823994-60-0
|
H-VSVFVPPR-OH
|
|
|
2-Chloronaphthalen-1-ol
|
|
606-40-6
|
2-Amino-3-[4-(dihydroxyboranyl)-2-fluorophenyl]propanoic acid
|
|
292050-22-7
|
2-Fluoro-4-(4-fluorophenyl)phenol
|
|
168158-52-9
|
Protein 4E-BP1 (initiation factor eIF-4-binding protein 1) (human)
|
|
185703-54-2
|
Notoginsenoside T1
|
|
343962-53-8
|
5-Iodofuran-2-carboxylic acid
|
|
18614-11-4
|
H-SSLPFQNI-OH
|
|
|
N-Phenylpiperidine-4-carboxamide
|
|
73415-85-7
|
2-Cycloheptyl-2-hydroxyacetic acid
|
|
18537-84-3
|
2-Hydroxy-5-[(2-methoxyphenyl)sulfamoyl]benzoic acid
|
|
262282-50-8
|
Methyl 5-amino-2-chloropyridine-3-carboxylate
|
|
886435-73-0
|
±-Amylcinnamaldehyde
|
|
122-40-7
|
p57 Kip2 antibody (Thr310)
|
|
|
Myelin Basic Protein (87-99) (human, bovine, rat)
|
|
118506-26-6
|
Ethyl 2,2-difluoro-3-methylbut-3-enoate
|
|
1936641-34-7
|
tert-Butyl 6-amino-1,4-thiazepane-4-carboxylate 1,1-dioxide
|
|
1369503-78-5
|
ALG13 antibody
|
|
|
N-(1-Amino-3,3-dimethylbutan-2-yl)-3-methoxyaniline
|
|
1489008-67-4
|
(2Z)-2-(Hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.4]non-3-ene
|
|
4575-53-5
|
3H,4H,6H,7H-Pyrano[3,4-d]imidazole-2-carbaldehyde
|
|
1341086-36-9
|
2-Amino-N-[(2-chlorophenyl)methyl]-4,5-dimethylbenzene-1-sulfonamide
|
|
1036616-28-0
|
N-Nitrosopiperidine-d10
|
|
960049-21-2
|
7-(tert-Butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid
|
|
1268520-63-3
|
5-(4-Fluorophenyl)-1,3-oxazole-2-thiol
|
|
923218-69-3
|
CTNNA3 antibody
|
|
|
6'-Fluoro-3',4'-dihydro-1'H-spiro[cyclobutane-1,2'-quinoxaline]-3'-one
|
|
1503582-73-7
|
LRRC49 Blocking Peptide
|
|
|
2,2-Dimethyl-3-(4-nitrophenyl)cyclobutan-1-one
|
|
1271911-39-7
|
1-(1,2-Dimethyl-1H-1,3-benzodiazol-6-yl)ethan-1-one
|
|
908100-64-1
|
1-(2-(1-bromo(2-naphthyloxy))acetyl)-4-phenyl-3-thiosemicarbazide
|
|
349469-29-0
|
SARS-CoV-2 NSP7 (1-15)
|
|
|
MAP1S antibody (FITC)
|
|
|
CYMAL-6 neopentyl glycol
|
|
|
1-(3,3,3-Trifluoropropyl)-1H-pyrazole-5-carboxylic acid
|
|
1245772-05-7
|
3-[(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1-methyl-1H-pyrazole-4-carboxylic acid
|
|
1801270-07-4
|
tert-Butyl 2-(3,4-dihydro-2H-pyran-5-yl)-2-oxoacetate
|
|
1432680-06-2
|
(E)-3-[3'-(4'-fluorophenyl)-1'-(1'-methylethyl)-1H-indol-2'-yl]-2-propnal
|
|
93957-50-7
|
2,4,6-Tris(propan-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzene-1-sulfonamide
|
|
300574-86-1
|
Methyl 1-methyl-1,2,3,4-tetrahydronaphthalene-1-carboxylate
|
|
113967-23-0
|
Boc-2-chloro-L-phenylalanine
|
|
114873-02-8
|
1-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethan-1-amine hydrochloride
|
|
1909337-88-7
|
PTDSS1 Blocking Peptide
|
|
|
2-Chloro-N-(1-phenylbutyl)acetamide
|
|
40023-34-5
|
CDYL2 Blocking Peptide
|
|
|
4,4' -Dihydroxy-3,3'-biphenyldicarboxylic acid
|
|
13987-45-6
|
Besilesomab
|
|
537694-98-7
|
Ethyl 2-(thian-4-yl)acetate
|
|
218624-29-4
|
1-(Prop-2-en-1-yl)cyclopentane-1-carboxylic acid
|
|
411238-08-9
|
2-Chloro-N-[4-(4-ethylphenyl)-1,3-thiazol-2-yl]-2-phenylacetamide
|
|
565166-64-5
|
3-Methyl-1-(pyridin-2-ylmethyl)piperazine dihydrochloride
|
|
1803580-63-3
|
H-DTEEEDFHVDQVTTVK^-OH
|
|
|
p62 antibody (C-terminal)
|
|
|
H-GEYLPLLQGK-OH
|
|
|
anti-E.coli O157 Antibody Monoclonal
|
|
|
2-Nitrophenyl 2-acetamido-2-deoxy-a-D-galactopyranoside
|
|
23646-67-5
|
H-VYVEELKPTPEGDLEILLQK^-OH
|
|
|
2'-Deoxy-5'-O-DMT-N2-(4-isopropylphenoxyacetyl)guanosine
|
|
909415-65-2
|
Chalcone
|
|
94-41-7
|
5-(Methoxycarbonyl)thieno[2,3-b]thiophene-2-carboxylic acid
|
|
2225136-06-9
|
(R)-Apremilast
|
|
608141-44-2
|
3-ethyl-5-((3-phenoxyphenyl)methylene)-2-thioxo-1,3-thiazolidin-4-one
|
|
359899-51-7
|
5-(tert-Butylamino)-N'-hydroxypyridine-2-carboximidamide
|
|
1443987-56-1
|
N-Cbz-L-valine
|
|
1149-26-4
|
4-Chloro-3-nitrobenzylamine hydrochloride
|
|
116599-39-4
|
6-Isopropoxynicotinic acid
|
|
223127-05-7
|
[2-(4-Fluorophenoxy)ethyl](2-methoxyethyl)amine
|
|
420098-40-4
|
Cis-3-(tert-butoxycarbonyl)cyclobutanecarboxylic acid
|
|
1212288-54-4
|
ASPHD2 antibody
|
|
|
4-Chloro-3,5-bis(difluoromethyl)-1H-pyrazole
|
|
1092769-15-7
|
[1-(2,2-Dimethylmorpholin-4-yl)cyclohexyl]methanamine
|
|
1155544-20-9
|
1-(2-Methoxyethyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid
|
|
1234914-99-8
|